Is dapsone safe? Topical vs oral risk, explained

Last updated 2026-07-27

Is dapsone safe to use for acne?

Topical dapsone gel, sold as Aczone in 5% and 7.5% strengths, is FDA-approved for acne vulgaris in people 9 years and older, and it's the version almost everyone asking this question actually means ^[1]. It's applied to the skin once a day. Absorption into the bloodstream is low, which is why the safety profile looks nothing like the oral drug's. The FDA approved Aczone 7.5% gel in 2016 based on two 12-week trials with over 4,300 patients, and the most common side effects were dryness, redness, and oiliness at the application site, not blood problems ^[1]. That's a very different risk conversation than the one you have about oral dapsone. There is one real caveat worth knowing. A small number of people with G6PD deficiency have developed lab evidence of hemolysis or methemoglobinemia even from topical use, though it's rare and generally mild compared to oral exposure. The Aczone label still carries a note about this population ^[1]. If you know you're G6PD deficient, mention it before starting, but for most people the topical route doesn't require blood testing the way oral dapsone does. So: is it safe? For the FDA-approved topical use, yes, for the overwhelming majority of users, with skin irritation being the main complaint. The safety story changes completely once you're talking about swallowing dapsone pills.

What's the difference between topical and oral dapsone?

Topical dapsone treats acne on the skin's surface with minimal systemic absorption. Oral dapsone is a sulfone antibiotic, absorbed fully into the bloodstream, and it's approved for dermatitis herpetiformis and leprosy (Hansen's disease), not for acne ^[2]. The distinction matters because the entire risk profile flips once dapsone enters systemic circulation. Oral dapsone routinely causes some degree of hemolysis (red blood cell breakdown) in nearly everyone who takes it, dose-dependently, because of how the drug is metabolized. Topical use largely sidesteps this because so little drug reaches the blood. A few dermatologists do prescribe oral dapsone off-label for severe, treatment-resistant acne or acne with heavy inflammatory/cystic components, but this is not standard first-line care. It comes with the full oral-drug risk package described below, including mandatory G6PD screening. If a prescriber suggests oral dapsone for ordinary acne, ask why topical retinoids, topical or oral antibiotics, or hormonal therapy haven't been tried first. If you're starting topical treatment and want to get dosing right from day one, the Dapsone Rx dosage guide and dosage calculator walk through strength selection and application frequency.

Why does oral dapsone require G6PD testing?

Oral dapsone requires G6PD (glucose-6-phosphate dehydrogenase) testing beforehand because people with this enzyme deficiency are at sharply higher risk of severe hemolytic anemia on the drug. G6PD protects red blood cells from oxidative stress, and dapsone's metabolites are oxidizing agents. The FDA label for oral dapsone tablets states that hemolysis is dose-related and that patients should be monitored for hematologic effects, with particular caution in G6PD-deficient patients, since hemolysis can be severe in this group ^[2]. MedlinePlus, the NIH's consumer drug reference, notes that dapsone "may cause a severe decrease in the number of red blood cells" and that doctors will order blood tests before and during treatment to check for this ^[3]. G6PD deficiency is not rare. It affects an estimated 400 million people worldwide and is most common in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent, according to the CDC ^[4]. Many people don't know their status until they're tested or until they have a reaction to an oxidizing drug or food (fava beans are the classic example). This is the single most important safety gate for oral dapsone. Any prescriber offering oral dapsone without discussing G6PD testing first is skipping a step that exists specifically to prevent hospitalizations.

What are the serious side effects of oral dapsone?

Oral dapsone's serious risks include hemolytic anemia, methemoglobinemia, agranulocytosis, and dapsone hypersensitivity syndrome, on top of more common effects like nausea, headache, and peripheral neuropathy. These are documented in clinical literature on sulfone toxicity ^[2][5]. Hemolytic anemia. Nearly universal at higher doses, more severe in G6PD deficiency, and monitored through regular complete blood counts during treatment ^[2][3]. Methemoglobinemia. Dapsone oxidizes hemoglobin into a form that can't carry oxygen properly, causing symptoms from fatigue and shortness of breath to, at high levels, cyanosis and organ stress ^[3]. Agranulocytosis. A rare but dangerous drop in infection-fighting white blood cells, usually appearing in the first few months of therapy, which is why bloodwork monitoring is standard practice on oral dapsone ^[2]. Dapsone hypersensitivity syndrome. A rare, potentially fatal reaction that typically appears 2 to 6 weeks after starting the drug, featuring fever, rash, and organ involvement (often liver). It resembles DRESS syndrome seen with other drugs and requires immediate discontinuation and often hospitalization ^[5]. None of this applies in the same way to topical dapsone, where systemic drug levels are too low to typically trigger these syndromes. That gap is exactly why conflating the two products in casual conversation is a real safety hazard, not a technicality.

Who should not take dapsone (topical or oral)?

People with known G6PD deficiency, anyone with a prior hypersensitivity reaction to dapsone or sulfones, and people with significant anemia should not take oral dapsone without specialist supervision. For topical dapsone, the main caution groups are people with G6PD deficiency (rare topical hemolysis has been reported) and anyone with a known allergy to dapsone or its ingredients ^[1][2]. Pregnancy and breastfeeding deserve a direct conversation with a prescriber for either form. Dapsone crosses into breast milk and there is a documented risk of hemolytic anemia in newborns of mothers taking oral dapsone, per case literature referenced in drug safety reviews ^[3]. Topical use has much lower systemic exposure, but it's still a decision to make with a clinician rather than alone. People on other oxidizing drugs, other sulfa-based medications, or drugs that raise dapsone levels (like trimethoprim) need extra caution with the oral form because interactions can worsen hemolysis or methemoglobinemia risk ^[2]. If none of this applies to you and you're using topical dapsone as directed for acne, you're in the low-risk group the FDA approval was built around.

What monitoring or testing does dapsone require?

Oral dapsone requires G6PD testing before starting, plus regular complete blood counts (CBCs). A common schedule is weekly for the first month, every two weeks for the next two months, and periodically after that, following dermatology monitoring protocols referenced in clinical guidance for dapsone therapy ^[2][5]. Liver function tests are often added given the hypersensitivity syndrome's tendency to involve the liver. Topical dapsone does not carry a routine bloodwork requirement in the FDA label for the general population, because systemic absorption is low ^[1]. If you have known G6PD deficiency and your prescriber still wants to try topical dapsone, they may order baseline labs out of caution, but this isn't the norm for most users. The practical takeaway: if a prescriber puts you on oral dapsone and doesn't mention baseline labs or a monitoring schedule, that's worth questioning directly. This isn't optional paperwork, it's how agranulocytosis and severe hemolysis get caught early instead of late.

How common are dapsone side effects, and how serious are they usually?

For topical dapsone, side effects are common but mostly mild. In FDA trials of Aczone 7.5% gel, application-site dryness, oiliness, and erythema were the most frequently reported effects, and serious systemic reactions were rare ^[1]. Most people tolerate it well over months of daily use. For oral dapsone, mild dose-related hemolysis is close to universal at standard therapeutic doses, but severe hemolysis, agranulocytosis, and hypersensitivity syndrome are much less common, though they are the reason for the monitoring schedule above. Agranulocytosis, in particular, has been estimated at roughly 0.2 to 0.4% of patients in older case series on sulfone therapy, though estimates vary by population and dose, and modern dermatology sources treat it as rare but serious enough to justify routine CBC monitoring ^[2][5]. Here's a simple side-by-side. | | Topical dapsone (Aczone 5%/7.5%) | Oral dapsone |

Is Dapsone a legitimate or safe source for dapsone?

Dapsone Rx operates as a provider-reviewed pathway, meaning a licensed clinician reviews your history (including G6PD status where relevant) before any prescription moves forward. Fulfillment runs through a licensed pharmacy partner rather than the platform itself compounding or manufacturing anything. That structure matters because the actual safety of dapsone therapy depends heavily on whether appropriate screening and monitoring happen before and during treatment, more than on the molecule itself. What makes any dapsone source safe or unsafe isn't the brand name. It's whether G6PD screening happens before oral use, whether a real prescriber is reviewing your case, and whether the product is a legitimate FDA-approved formulation rather than an unregulated compound of unknown purity. Buying dapsone from unverified overseas sellers or gray-market sites skips every one of those safeguards. If you're figuring out dosing specifics after a legitimate prescription is in hand, the dosage calculator and guidance on cycle length are useful next steps, and if your regimen involves an injectable or compounded form, see how to reconstitute, injection technique, and injection site selection.

How do you know if you're G6PD deficient before starting dapsone?

A simple blood test measures G6PD enzyme activity, and it's the standard step any responsible prescriber orders before starting oral dapsone. It's a one-time test in most cases, not an ongoing one, since G6PD status doesn't change over time. The CDC notes G6PD deficiency is X-linked, meaning it's more common and often more severe in males, and prevalence is notably higher in people with ancestry from malaria-endemic regions including parts of Africa, the Mediterranean, the Middle East, and Southeast Asia, with estimates citing around 400 million people affected globally ^[4]. That's not a niche population. It's a meaningful chunk of anyone's patient panel, which is exactly why testing before oral dapsone is standard rather than optional. If you don't know your G6PD status and a clinician proposes oral dapsone, ask for the test first. It's inexpensive, it's a single blood draw, and it directly changes whether oral dapsone is appropriate for you at all.

Can you take dapsone if you're pregnant or breastfeeding?

Oral dapsone during pregnancy needs a direct risk-benefit conversation with a specialist, since it crosses the placenta and there's documented risk of neonatal hemolytic anemia and hyperbilirubinemia when used near delivery, based on drug information reviewed by the NIH ^[3]. It's sometimes still used for conditions like dermatitis herpetiformis when the benefit outweighs risk, but that's a specialist decision, not a self-directed one. Breastfeeding carries similar caution: dapsone passes into breast milk, and case reports describe hemolytic anemia in nursing infants of mothers on oral dapsone ^[3]. Topical dapsone's systemic exposure is far lower, so many clinicians view it as a lower-risk option during pregnancy or breastfeeding for acne, but the honest answer is that dedicated large-scale safety trials in pregnant populations are limited for both forms, so this stays a conversation with your OB or dermatologist rather than a blanket yes or no.

What should you do if you think you're having a dapsone reaction?

Stop the medication and contact your prescriber or seek urgent care immediately if you notice fever, rash, yellowing skin or eyes, unusual fatigue, shortness of breath, or bluish-colored skin or lips while on oral dapsone. These can be early signs of hemolysis, methemoglobinemia, or dapsone hypersensitivity syndrome, and hypersensitivity syndrome in particular can turn serious within days of symptom onset ^[2][5]. For topical dapsone, significant reactions are far less common, but stop use and call your prescriber for any signs of unusual paleness, yellowing skin, dark urine, or unexplained fatigue, since these could indicate hemolysis even from topical exposure in a G6PD-deficient person ^[1]. Don't wait out symptoms hoping they resolve. Dapsone hypersensitivity syndrome specifically has a reported mortality rate in some case series high enough that dermatology guidance treats any fever-plus-rash combination in the first weeks of oral therapy as an emergency, not a wait-and-see situation ^[5].

Frequently asked questions

Is dapsone gel safe for long-term acne use?

Yes, for most people. FDA trials followed patients for 12 weeks, and long-term clinical experience since the 2005 (5%) and 2016 (7.5%) approvals shows the main issue is ongoing mild skin dryness or irritation, not systemic toxicity, since absorption into the bloodstream stays low with topical use ^[1].

Does topical dapsone require a G6PD test?

Not routinely for most users, because systemic absorption is low. But rare cases of hemolysis or methemoglobinemia have occurred in G6PD-deficient people even with topical use, so if you already know you're G6PD deficient, tell your prescriber before starting ^[1].

Why does oral dapsone cause anemia?

Dapsone's metabolites oxidize hemoglobin and red blood cell membranes, causing red cells to break down faster than normal, a process called hemolysis. This happens to some degree in most people on oral dapsone above roughly 200 mg/day, and it's much more severe in people with G6PD deficiency ^[2].

Can dapsone cause a fatal reaction?

Rarely, yes. Dapsone hypersensitivity syndrome and severe agranulocytosis are uncommon but documented serious reactions to oral dapsone, sometimes requiring hospitalization, and case reports describe fatalities in severe untreated cases, which is why routine bloodwork monitoring exists during oral therapy ^[2][5].

Is oral dapsone used for acne?

Not as standard care. Oral dapsone is FDA-approved for dermatitis herpetiformis and leprosy, not acne ^[2]. Some dermatologists use it off-label for severe resistant acne, but this requires G6PD testing and monitoring, and it's not a first-line or casual option.

What's the difference between Aczone and dapsone?

Aczone is the FDA-approved brand name for topical dapsone gel (5% and 7.5%), used specifically for acne ^[1]. "Dapsone" alone often refers to the oral tablet form used for dermatitis herpetiformis and leprosy, which carries much higher systemic risk.

How is G6PD deficiency tested before dapsone treatment?

It's a single blood test measuring G6PD enzyme activity in red blood cells, typically ordered once before starting oral dapsone since G6PD status doesn't change over a lifetime. It's inexpensive and standard practice before oral sulfone therapy ^[3][4].

Who is most at risk for G6PD deficiency?

G6PD deficiency is X-linked and affects an estimated 400 million people worldwide, more common in males and in people with ancestry from Africa, the Mediterranean, the Middle East, and Southeast Asia, according to the CDC ^[4].

What are early warning signs of a dapsone problem?

Fever, rash, unusual fatigue, yellowing skin or eyes, dark urine, shortness of breath, or bluish skin color while on oral dapsone are warning signs that need immediate medical attention, since they can signal hemolysis, methemoglobinemia, or hypersensitivity syndrome ^[2][3][5].

Can you buy dapsone online safely?

Only through a route involving real clinician review, appropriate screening (G6PD testing for oral forms), and a licensed pharmacy for fulfillment. Unverified overseas sellers or compounders skip these safeguards entirely, which is the actual safety risk, not the drug name itself.

Does dapsone interact with other medications?

Yes. Drugs like trimethoprim can raise dapsone blood levels and worsen hemolysis or methemoglobinemia risk, and other oxidizing or sulfa-based drugs can compound risk ^[2]. Always share your full medication list with your prescriber before starting oral dapsone.

How often is bloodwork needed on oral dapsone?

A common monitoring schedule is weekly CBCs for the first month, every two weeks for the next two months, then periodically after that, based on dermatology monitoring guidance for dapsone therapy, alongside liver function checks given hypersensitivity syndrome risk ^[2][5].

Sources

1. FDA, Aczone (dapsone) 7.5% Gel prescribing information: FDA approval, indication, trial data, common side effects, and G6PD caution for topical dapsone
2. DailyMed (NIH/NLM), Dapsone tablets USP prescribing information: Oral dapsone indications, hemolysis, agranulocytosis, drug interactions
3. MedlinePlus (NIH), Dapsone drug information: Monitoring requirements, pregnancy/breastfeeding hemolysis risk, blood cell effects
4. CDC, Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD) fact sheet: G6PD deficiency prevalence and affected populations
5. StatPearls (NIH/NCBI Bookshelf), Dapsone Toxicity: Dapsone hypersensitivity syndrome timeline, agranulocytosis, monitoring recommendations